Cargando…

Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine–Levin syndrome: an early marker?

Kleine–Levin syndrome is a rare disorder characterized by relapsing-remitting episodes of severe hypersomnia, cognitive impairment, apathy, derealization and behavioural disturbances. Between episodes, most patients experience normal sleep, mood and behaviour, but they may have some residual abnorma...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudoignon, Benjamin, Tainturier, Laure-Eugénie, Dodet, Pauline, Bera, Géraldine, Groos, Elisabeth, Chaumereuil, Charlotte, Maranci, Jean-Baptiste, Kas, Aurélie, Arnulf, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226192/
https://www.ncbi.nlm.nih.gov/pubmed/34189461
http://dx.doi.org/10.1093/braincomms/fcab130
_version_ 1783712235835621376
author Dudoignon, Benjamin
Tainturier, Laure-Eugénie
Dodet, Pauline
Bera, Géraldine
Groos, Elisabeth
Chaumereuil, Charlotte
Maranci, Jean-Baptiste
Kas, Aurélie
Arnulf, Isabelle
author_facet Dudoignon, Benjamin
Tainturier, Laure-Eugénie
Dodet, Pauline
Bera, Géraldine
Groos, Elisabeth
Chaumereuil, Charlotte
Maranci, Jean-Baptiste
Kas, Aurélie
Arnulf, Isabelle
author_sort Dudoignon, Benjamin
collection PubMed
description Kleine–Levin syndrome is a rare disorder characterized by relapsing-remitting episodes of severe hypersomnia, cognitive impairment, apathy, derealization and behavioural disturbances. Between episodes, most patients experience normal sleep, mood and behaviour, but they may have some residual abnormalities in brain functional imaging; however, the frequency, localization and significance of abnormal imaging are unknown, as brain functional imaging have been scarce and heterogenous [including scintigraphy 18F-fluorodeoxyglucose positron emission tomography/computerized tomography (FDG-PET/CT) and functional MRI during resting state and cognitive effort] and based on case reports or on group analysis in small groups. Using visual individual analysis of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography at the time of Kleine–Levin syndrome diagnosis, we examined the frequency, localization and clinical determinants of hypo- and hypermetabolism in a cross-sectional study. Among 179 patients with Kleine–Levin syndrome who underwent 18F-fluorodeoxyglucose positron emission tomography/computerized tomography, the visual analysis was restricted to the 138 untreated patients studied during asymptomatic periods. As many as 70% of patients had hypometabolism, mostly affecting the posterior associative cortex and the hippocampus. Hypometabolism was associated with younger age, recent (<3 years) disease course and a higher number of episodes during the preceding year. The hypometabolism was more extensive (from the left temporo-occipital junction to the entire homolateral and then the bilateral posterior associative cortex) at the beginning of the disorder. In contrast, there was hypermetabolism in the prefrontal dorsolateral cortex in half of the patients (almost all having concomitant hypometabolism in the posterior areas), which was also associated with younger age and shorter disease course. The cognitive performances (including episodic memory) were similar in patients with versus without hippocampus hypometabolism. In conclusion, hypometabolism is frequently observed upon individual visual analysis of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography during asymptomatic Kleine–Levin syndrome periods; it is mostly affecting the posterior associative cortex and the hippocampus and is mostly in young patients with recent-onset disease. Hypometabolism provides a trait marker during the first years of Kleine–Levin syndrome, which could help clinicians during the diagnosis process.
format Online
Article
Text
id pubmed-8226192
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82261922021-06-28 Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine–Levin syndrome: an early marker? Dudoignon, Benjamin Tainturier, Laure-Eugénie Dodet, Pauline Bera, Géraldine Groos, Elisabeth Chaumereuil, Charlotte Maranci, Jean-Baptiste Kas, Aurélie Arnulf, Isabelle Brain Commun Original Article Kleine–Levin syndrome is a rare disorder characterized by relapsing-remitting episodes of severe hypersomnia, cognitive impairment, apathy, derealization and behavioural disturbances. Between episodes, most patients experience normal sleep, mood and behaviour, but they may have some residual abnormalities in brain functional imaging; however, the frequency, localization and significance of abnormal imaging are unknown, as brain functional imaging have been scarce and heterogenous [including scintigraphy 18F-fluorodeoxyglucose positron emission tomography/computerized tomography (FDG-PET/CT) and functional MRI during resting state and cognitive effort] and based on case reports or on group analysis in small groups. Using visual individual analysis of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography at the time of Kleine–Levin syndrome diagnosis, we examined the frequency, localization and clinical determinants of hypo- and hypermetabolism in a cross-sectional study. Among 179 patients with Kleine–Levin syndrome who underwent 18F-fluorodeoxyglucose positron emission tomography/computerized tomography, the visual analysis was restricted to the 138 untreated patients studied during asymptomatic periods. As many as 70% of patients had hypometabolism, mostly affecting the posterior associative cortex and the hippocampus. Hypometabolism was associated with younger age, recent (<3 years) disease course and a higher number of episodes during the preceding year. The hypometabolism was more extensive (from the left temporo-occipital junction to the entire homolateral and then the bilateral posterior associative cortex) at the beginning of the disorder. In contrast, there was hypermetabolism in the prefrontal dorsolateral cortex in half of the patients (almost all having concomitant hypometabolism in the posterior areas), which was also associated with younger age and shorter disease course. The cognitive performances (including episodic memory) were similar in patients with versus without hippocampus hypometabolism. In conclusion, hypometabolism is frequently observed upon individual visual analysis of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography during asymptomatic Kleine–Levin syndrome periods; it is mostly affecting the posterior associative cortex and the hippocampus and is mostly in young patients with recent-onset disease. Hypometabolism provides a trait marker during the first years of Kleine–Levin syndrome, which could help clinicians during the diagnosis process. Oxford University Press 2021-06-17 /pmc/articles/PMC8226192/ /pubmed/34189461 http://dx.doi.org/10.1093/braincomms/fcab130 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Dudoignon, Benjamin
Tainturier, Laure-Eugénie
Dodet, Pauline
Bera, Géraldine
Groos, Elisabeth
Chaumereuil, Charlotte
Maranci, Jean-Baptiste
Kas, Aurélie
Arnulf, Isabelle
Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine–Levin syndrome: an early marker?
title Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine–Levin syndrome: an early marker?
title_full Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine–Levin syndrome: an early marker?
title_fullStr Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine–Levin syndrome: an early marker?
title_full_unstemmed Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine–Levin syndrome: an early marker?
title_short Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine–Levin syndrome: an early marker?
title_sort functional brain imaging using 18f-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with kleine–levin syndrome: an early marker?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226192/
https://www.ncbi.nlm.nih.gov/pubmed/34189461
http://dx.doi.org/10.1093/braincomms/fcab130
work_keys_str_mv AT dudoignonbenjamin functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker
AT tainturierlaureeugenie functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker
AT dodetpauline functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker
AT berageraldine functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker
AT grooselisabeth functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker
AT chaumereuilcharlotte functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker
AT marancijeanbaptiste functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker
AT kasaurelie functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker
AT arnulfisabelle functionalbrainimagingusing18ffluorodeoxyglucosepositronemissiontomographycomputerizedtomographyin138patientswithkleinelevinsyndromeanearlymarker